Cardlytics Share Price Today
(NASDAQ: CDLX)

Name: Cardlytics Share Price Today (NASDAQ: CDLX) - Cardlytics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Cardlytics share price is $2.43 & ₹211.33 as on 6 Mar 2025, 2.30 'hrs' IST

$2.43

Market is closed - opens 8 PM, 06 Mar 2025

View live Cardlytics share price in Dollar and Rupees. Guide to invest in Cardlytics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cardlytics, along with analyst recommendations, forecasts, and comprehensive financials.

Cardlytics share price movements

Today's Low: $2.30
Today's High: $2.44
$2.43
5.56%
Downside
Day's Volatility :5.94%
Upside
0.41%
52 Weeks Low: $2.26
52 Weeks High: $20.52
$2.43
7.2%
Downside
52 Weeks Volatility :89.01%
Upside
88.16%

Cardlytics (CDLX) Returns

Period	Cardlytics Inc	Sector (Communication Services)	Index (Russel 2000)
3 Months	-36.55%	0.5%	0.0%
6 Months	-30.77%	21.1%	0.0%
1 Year	-64.99%	29.4%	0.0%
3 Years	-95.3%	52.6%	-11.6%

Cardlytics (CDLX) Key Statistics

in dollars & INR

Previous Close	$2.435
Open	$2.41
Today's High	$2.44
Today's Low	$2.295
Market Capitalization	$123.5M
Today's Volume	$759.1K
52 Week High	$20.52
52 Week Low	$2.255
Revenue TTM	$293.5M
EBITDA	$-36.6M
Earnings Per Share (EPS)	$-6.4
Profit Margin	-93.55%
Quarterly Earnings Growth YOY	-0.57%
Return On Equity TTM	-186.12%

How to invest in Cardlytics Stock (CDLX) from India?

It is very easy for Indian residents to invest directly in Cardlytics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cardlytics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cardlytics or CDLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cardlytics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cardlytics shares which would translate to 0.358 fractional shares of Cardlytics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cardlytics, in just a few clicks!

Returns in Cardlytics (CDLX) for Indian investors in Rupees

The Cardlytics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Cardlytics investment value today

Current value as on today

₹39,963

Returns

₹60,037

(-60.04%)

Returns from Cardlytics Stock

₹64,986 (-64.99%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cardlytics (CDLX)

38%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cardlytics Stock from India on INDmoney has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cardlytics

BlackRock Inc
6.35%
Vanguard Group Inc
5.30%
683 Capital Management LLC
2.58%
KPS Global Asset Management UK Ltd
2.40%
Worldly Partners Management LLC
2.28%
Mirabella Financial Services LLP
2.27%

Analyst Recommendation on Cardlytics

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Cardlytics(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cardlytics Stock (CDLX)

What analysts predicted

Upside of 81.07%

Target:

$4.40

Current:

$2.43

Insights on Cardlytics Stock (Ticker Symbol: CDLX)

Price Movement
In the last 3 months, CDLX stock has moved down by -38.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 69.63M → 67.05M (in $), with an average decrease of 3.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -4.25M → -145.18M (in $), with an average decrease of 3310.4% per quarter
CDLX vs MGNI (1 yr)
In the last 1 year, Magnite Inc. has given 24.7% return, outperforming this stock by 89.7%
CDLX vs CRTO (3 yr)
In the last 3 years, Criteo Sa has given 14.5% return, outperforming this stock by 110.0%
Price to Sales
ForCDLX every $1 of sales, investors are willing to pay $0.4, whereas for Magnite Inc., the investors are paying $3.0 for every $1 of sales.

CDLX Cardlytics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$150.7M	↑ 15.59%
Net Income	$-53.0M	↑ 170.06%
Net Profit Margin	-35.2%	↓ 20.13%

	FY19	Y/Y Change
Revenue	$210.4M	↑ 39.65%
Net Income	$-17.7M	↓ 66.65%
Net Profit Margin	-8.41%	↑ 26.79%

	FY20	Y/Y Change
Revenue	$186.9M	↓ 11.19%
Net Income	$-58.5M	↑ 230.49%
Net Profit Margin	-31.29%	↓ 22.88%

	FY21	Y/Y Change
Revenue	$267.1M	↑ 42.93%
Net Income	$-128.6M	↑ 119.88%
Net Profit Margin	-48.13%	↓ 16.84%

	FY22	Y/Y Change
Revenue	$298.5M	↑ 11.76%
Net Income	$-465.3M	↑ 261.89%
Net Profit Margin	-155.85%	↓ 107.72%

	FY23	Y/Y Change
Revenue	$309.2M	↑ 3.57%
Net Income	$-134.7M	↓ 71.05%
Net Profit Margin	-43.56%	↑ 112.29%

	Q2 FY23	Q/Q Change
Revenue	$76.7M	↑ 12.92%
Net Income	$-23.5M	↓ 171.15%
Net Profit Margin	-30.65%	↓ 79.29%

	Q3 FY23	Q/Q Change
Revenue	$79.0M	↑ 3.0%
Net Income	$-24.0M	↑ 1.95%
Net Profit Margin	-30.33%	↑ 0.32%

	Q4 FY23	Q/Q Change
Revenue	$89.2M	↑ 12.86%
Net Income	$-100.8M	↑ 320.75%
Net Profit Margin	-113.09%	↓ 82.76%

	Q1 FY24	Q/Q Change
Revenue	$67.6M	↓ 24.18%
Net Income	$-24.3M	↓ 75.93%
Net Profit Margin	-35.91%	↑ 77.18%

	Q2 FY24	Q/Q Change
Revenue	$69.6M	↑ 3.0%
Net Income	$-4.3M	↓ 82.46%
Net Profit Margin	-6.11%	↑ 29.8%

	Q3 FY24	Q/Q Change
Revenue	$67.1M	↓ 3.7%
Net Income	$-145.2M	↑ 3310.43%
Net Profit Margin	-216.51%	↓ 210.4%

	FY18	Y/Y Change
Profit	$54.7M	↑ 9.13%

	FY19	Y/Y Change
Profit	$79.5M	↑ 45.31%

	FY20	Y/Y Change
Profit	$63.3M	↓ 20.37%

	FY21	Y/Y Change
Profit	$103.3M	↑ 63.32%

	FY22	Y/Y Change
Profit	$112.6M	↑ 8.99%

	FY23	Y/Y Change
Profit	$130.4M	↑ 15.76%

	Q2 FY23	Q/Q Change
Profit	$30.5M	↑ 16.29%

	Q3 FY23	Q/Q Change
Profit	$35.8M	↑ 17.48%

	Q4 FY23	Q/Q Change
Profit	$40.6M	↑ 13.23%

	Q1 FY24	Q/Q Change
Profit	$30.8M	↓ 24.09%

	Q2 FY24	Q/Q Change
Profit	$29.8M	↓ 3.13%

	Q3 FY24	Q/Q Change
Profit	$28.6M	↓ 4.35%

	FY18	Y/Y Change
Operating Cash Flow	$-19.0M	↓ 14.06%
Investing Cash Flow	$-7.3M	↑ 345.78%
Financing Cash Flow	$65.2M	↑ 199.58%

	FY19	Y/Y Change
Operating Cash Flow	$11.5M	↓ 160.32%
Investing Cash Flow	$-11.0M	↑ 50.1%
Financing Cash Flow	$44.2M	↓ 32.23%

	FY20	Y/Y Change
Operating Cash Flow	$-7.6M	↓ 166.32%
Investing Cash Flow	$-10.1M	↓ 8.19%
Financing Cash Flow	$206.4M	↑ 367.26%

	FY21	Y/Y Change
Operating Cash Flow	$-38.5M	↑ 407.02%
Investing Cash Flow	$-506.7M	↑ 4908.35%
Financing Cash Flow	$486.0M	↑ 135.43%

	FY22	Y/Y Change
Operating Cash Flow	$-53.9M	↑ 39.93%
Investing Cash Flow	$-15.8M	↓ 96.89%
Financing Cash Flow	$-40.0M	↓ 108.23%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$5.8M	↓ 157.14%
Investing Cash Flow	$-2.7M	↓ 1.96%
Financing Cash Flow	$-50.1M	↓ 267.03%

Cardlytics Technicals Summary

Sell

Neutral

Buy

Cardlytics is currently in a neutral trading position according to technical analysis indicators.

Cardlytics (CDLX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cardlytics Inc	-19.27%	-30.77%	-64.99%	-95.3%	-94.26%
Criteo Sa	-0.31%	-14.44%	15.65%	36.32%	286.28%
Integral Ad Science Holding Llc	-4.56%	-10.71%	10.33%	-41.29%	-50.19%
Omnicom Group Inc.	-5.4%	-17.72%	-9.26%	9.47%	-0.98%
Interpublic Group Of Companies, Inc.	-5.69%	-13.67%	-14.73%	-15.65%	48.99%
Magnite Inc.	-18.18%	5.0%	24.7%	23.11%	83.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cardlytics Inc	NA	NA	NA	-0.63	-1.86	-0.08	NA	1.38
Criteo Sa	19.87	19.87	0.89	4.57	0.1	0.05	NA	19.33
Integral Ad Science Holding Llc	47.45	47.45	NA	0.81	0.04	0.03	NA	6.19
Omnicom Group Inc.	10.82	10.82	1.22	8.46	0.32	0.05	0.03	21.35
Interpublic Group Of Companies, Inc.	14.84	14.84	148.47	2.63	0.18	0.05	0.05	10.2
Magnite Inc.	91.56	91.56	NA	0.9	0.03	0.01	NA	5.43

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cardlytics Inc	Buy	$123.5M	-94.26%	NA	-93.55%
Criteo Sa	Buy	$2.0B	286.28%	19.87	5.77%
Integral Ad Science Holding Llc	Buy	$1.7B	-50.19%	47.45	7.13%
Omnicom Group Inc.	Buy	$15.9B	-0.98%	10.82	9.44%
Interpublic Group Of Companies, Inc.	Buy	$10.1B	48.99%	14.84	7.51%
Magnite Inc.	Buy	$2.1B	83.42%	91.56	3.41%

About Cardlytics

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Organization	Cardlytics
Employees	456
CEO	Mr. Amit Gupta
Industry	Technology Services

Management People of Cardlytics

Name	Title
Mr. Amit Gupta	CEO & Director
Ms. Alexis DeSieno	Chief Financial Officer
Mr. Nick Lynton	Chief Legal & Privacy Officer and Secretary
Mr. Peter Chan	Chief Technology Officer
Ms. Carson Napps	Chief People Officer
Mr. Jose Singer	Chief Product Officer
Ms. Evelyne Forester	Chief Business Officer

Important FAQs about investing in CDLX Stock from India :

What is Cardlytics share price today?

Cardlytics share price today stands at $2.43, Open: $2.41 ; Previous Close: $2.44 ; High: $2.44 ; Low: $2.30 ; 52 Week High: $20.52 ; 52 Week Low: $2.26.

The stock opens at $2.41, after a previous close of $2.44. The stock reached a daily high of $2.44 and a low of $2.30, with a 52-week high of $20.52 and a 52-week low of $2.26.

Can Indians buy Cardlytics shares?

Yes, Indians can invest in the Cardlytics (CDLX) from India.

With INDmoney, you can buy Cardlytics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cardlytics at zero transaction cost.

How can I buy Cardlytics shares from India?

It is very easy to buy Cardlytics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cardlytics (CDLX) be purchased?

Yes, you can buy fractional shares of Cardlytics with INDmoney app.

What are the documents required to start investing in Cardlytics stocks?

To start investing in Cardlytics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.